Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

New ultra-specific test now available for prostate cancer

A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs.

27 Sep 2013

NeoTract treats first patient in US with UroLift System

NeoTract, Inc., today announced that the first patient in the United States has been treated with its commercial UroLift System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia in men 50 years of age or older.

24 Sep 2013

Partner yoga may help couples who are struggling with sexual dysfunction, say Loyola experts

Partner yoga may help couples who are struggling with sexual dysfunction, according to sexual wellness experts at Loyola University Health System (LUHS).

17 Sep 2013

Biostatistician uses statistical and computer modeling for policy development in prostate cancer research

Ruth Etzioni, Ph.D., a biostatistician, is a member of the Public Health Sciences Division at Fred Hutchinson Cancer Research Center.

29 Aug 2013

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has notified the Company that it is extending the Prescription Drug User Fee Act goal date for the Company's supplemental biologics license application for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease from September 6, 2013 to December 6, 2013.

28 Aug 2013

Loyola opens Sexual Wellness Clinic in September

Loyola University Health System will open a Sexual Wellness Clinic in September. This program will combine the expertise of various specialists to address common emotional and physical challenges that couples face in their sexual relationships.

19 Aug 2013

Loyola establishes Mother's Pelvic Wellness Program in Chicago area

Loyola University Health System has established the first multidisciplinary program in the Chicago area to help women recover from pelvic floor disorders related to pregnancy and childbirth.

13 Aug 2013

Ovary removal during hysterectomy protects against future risk of ovarian cancer

While ovary removal during hysterectomy protects against future risk of ovarian cancer, the decision to conserve the ovaries and the hormones they produce may have advantages for preventing heart disease, hip fracture, sexual dysfunction, and cognitive decline.

26 Jul 2013

Sprout Pharmaceuticals resubmits flibanserin NDA for treating HSDD in pre-menopausal women

Sprout Pharmaceuticals, the Raleigh-based pharmaceutical company developing flibanserin, a treatment being evaluated for Hypoactive Sexual Desire Disorder in pre-menopausal women, confirmed today that the company has resubmitted the New Drug Application for flibanserin earlier this year and expects US Food and Drug Agency action before the end of 2013.

27 Jun 2013

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Men's Health Network and Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, have announced the launch of a new health awareness program called "Ask About the Curve" to provide information about Peyronie's disease and to help empower men to have meaningful discussions about their condition with their partner and their healthcare provider.

11 Jun 2013

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Beaumont Health System research finds that symptoms of overactive bladder, or OAB, were reduced in those who received tibial nerve stimulation. The three-year results published in the June issue of The Journal of Urology show participants with urinary frequency, urgency and involuntary loss of urine maintained significant improvement in their symptoms.

31 May 2013

Apnix Sleep Diagnostics updates comprehensive sleep apnea treatments

Apnix Sleep Diagnostics has recently updated its comprehensive sleep apnea treatments, and is eager to serve more Houston sufferers of this condition.

31 May 2013

Weekend reading: Mental illness stigma, health insurance mazes and female libido

Linneah sat at a desk at the Center for Sexual Medicine at Sheppard Pratt in the suburbs of Baltimore and filled out a questionnaire. She read briskly, making swift checks beside her selected answers, and when she was finished, she handed the pages across the desk to Martina Miller, who gave her a round of pills.

24 May 2013

Research suggests that IMRT may not be more effective in patients who had prostatectomy

Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.

22 May 2013

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

A medication’s optimal results are achieved with specific dose levels and times of administration. In order for patients to achieve the maximum benefit from a medication, they have to adhere to the prescribed dose and time of use.

20 May 2013

Study: Image-guided brachytherapy prevents growth of cervical tumour in over 90% of patients

Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumour, and with fewer serious side-effects to the surrounding normal organs.

22 Apr 2013

Study confirms crizotinib drug reduces testosterone levels

A previous study by the University of Colorado Cancer Center reported the common side effect of low testosterone in men treated with the recently approved lung cancer agent, crizotinib.

17 Apr 2013

Review: Impact of TBI on sexuality and importance of rehabilitation strategies

Each year more than three million Americans are living with traumatic brain injury (TBI), a condition that is associated with physical, cognitive, and emotional problems that often affect their sexuality, and subsequently their marital stability, identity, and self-esteem.

7 Apr 2013

Continuous hormone therapy more effective for metastatic prostate cancer

A study published today in the New England Journal of Medicine recommends a dramatic shift in the way doctors treat metastatic prostate cancer.

5 Apr 2013

FDA accepts Ampio’s Patient Outcome for Premature Ejaculation questionnaire

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat prevalent inflammatory diseases, such as osteoarthritis (Ampion) and diabetic macular edema (Optina) and sexual dysfunction (Zertane) announced FDA acceptance of its POPE questionnaire, a modification of the Premature Ejaculation Profile (PEP) questionnaire that was used in the two successful Zertane Phase 3 clinical trials completed in Europe.

11 Mar 2013

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

New ultra-specific test now available for prostate cancer

NeoTract treats first patient in US with UroLift System

Partner yoga may help couples who are struggling with sexual dysfunction, say Loyola experts

Biostatistician uses statistical and computer modeling for policy development in prostate cancer research

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

Loyola opens Sexual Wellness Clinic in September

Loyola establishes Mother's Pelvic Wellness Program in Chicago area

Ovary removal during hysterectomy protects against future risk of ovarian cancer

Sprout Pharmaceuticals resubmits flibanserin NDA for treating HSDD in pre-menopausal women

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Apnix Sleep Diagnostics updates comprehensive sleep apnea treatments

Weekend reading: Mental illness stigma, health insurance mazes and female libido

Research suggests that IMRT may not be more effective in patients who had prostatectomy

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

Study: Image-guided brachytherapy prevents growth of cervical tumour in over 90% of patients

Study confirms crizotinib drug reduces testosterone levels

Review: Impact of TBI on sexuality and importance of rehabilitation strategies

Continuous hormone therapy more effective for metastatic prostate cancer

FDA accepts Ampio’s Patient Outcome for Premature Ejaculation questionnaire

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in